Drug Formulation and Manufacturing Contract II (DFMC)
SAM.GOV Due: May 12, 2025 at 09:00 PM UTC
In-Active Sources Sought SBP Source Url

Summary

The Drug Formulation and Manufacturing Contract II (DFMC) opportunity is a Sources Sought notice issued by the National Institutes of Health (NIH) aimed at identifying potential vendors capable of fulfilling the requirements for investigational drug products. The contract encompasses a comprehensive range of activities including manufacturing, documentation, formulation, fill and finish, packaging, and labeling. Contractors interested in this opportunity should possess the necessary technical capabilities and resources to meet the stringent compliance standards set forth by regulatory bodies such as the FDA and WHO. This contract builds upon the previous DFMC-I, with an expectation of increased task orders to support the NIH's centralized contracting efforts across its various institutes and centers. Businesses with experience in pharmaceutical manufacturing and a strong understanding of current good manufacturing practices (cGMP) are encouraged to respond to this notice.
Description

Please take a moment to thoroughly review the attached Statement of Work (SOW), which outlines the full scope and details of the drug formulation and manufacturing contract requirement.

The goal of the contract is to complete all the manufacturing, documentation, formulation, fill and fin

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325412
Set Aside
SBP : Partial Small Business Set-Aside (FAR 19.5)
Place of Performance
Rockville , Maryland 20852
Point of Contact
Full Name Email Phone Type
Dr. William H. M. Etti [email protected] 3014024422 primary
Attachments
  • New+DFMC+SOW_DRAFT+01Feb25+clean.docx